...Leonard, M.D., professor of medicine, discusses some of the exciting advancements taking place in the...
https://meyercancer.weill.cornell.edu/news/2022-07-28/dr-jedd-wolchok-appointed-meyer-director-sandra-and-edward-meye%C3%A2%C2%80%C2%A6?page=16
...Leonard, M.D., discusses the advance of precision medicine across hematologic malignancies....
https://meyercancer.weill.cornell.edu/news/2022-07-28/dr-jedd-wolchok-appointed-meyer-director-sandra-and-edward-meye%C3%A2%C2%80%C2%A6?page=15
...more 2015 Oct 07 Precision medicine in mantle cell lymphoma: Balancing logic with enthusiasm John Leonard...
https://meyercancer.weill.cornell.edu/news/2022-07-28/dr-jedd-wolchok-appointed-meyer-director-sandra-and-edward-meye%C3%A2%C2%80%C2%A6?page=42
...John Leonard, Sandra and Edward Meyer Cancer Center, Awards & Honors In Brief In Brief: How to Reduce...
https://news.weill.cornell.edu/people/dr-erica-phillips
...Leonard, who is also interim chair of the Weill Department of Medicine and the Richard T....
https://research.weill.cornell.edu/about-us/news-updates/building-trust-and-fostering-collaborations-key-startup-formation
...Leonard is also Associate Professor of Medicine at Weill Cornell Medical College....
https://news.weill.cornell.edu/news/2004/10/newyork-presbyterianweill-cornell-seeks-patients-with-mantle-cell-lymphoma-for-clinical-trial-with-v
...Leonard serves as a paid consultant for Celgene....
https://news.weill.cornell.edu/news/2015/11/new-drug-combination-suggests-promising-treatment-for-mantle-cell-lymphoma
...Leonard Girardi....
https://gca.weill.cornell.edu/news/simple-surgical-technique-associated-significant-reduction-risk-atrial-fibrillation-after
...Leonard Girardi, Dr. Nir Uriel, Dr. Steven J. Corwin, Dr....
https://news.weill.cornell.edu/news/2022/11/newyork-presbyterian-expands-heart-transplant-and-heart-failure-services
...Jia Ruan, Peter Martin, John Leonard, Olivier Elemento, and Ari Melnick....
https://meyercancer.weill.cornell.edu/news/2023-05-04/adding-epigenetic-drug-standard-chemotherapy-was-effective-pilot-study-t-cell